ID: ALA5207209

Max Phase: Preclinical

Molecular Formula: C14H23N5O6

Molecular Weight: 357.37

Representations

Canonical SMILES:  Nc1nc(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1CNCC[C@H](N)C(=O)O

Standard InChI:  InChI=1S/C14H23N5O6/c15-8(13(22)23)1-2-17-4-7-5-19(14(24)18-12(7)16)11-3-9(21)10(6-20)25-11/h5,8-11,17,20-21H,1-4,6,15H2,(H,22,23)(H2,16,18,24)/t8-,9-,10+,11+/m0/s1

Standard InChI Key:  RSZJXFKNJBHJCQ-UKKRHICBSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 357.37

Molecular Weight (Monoisotopic): 357.1648

AlogP: -2.64

#Rotatable Bonds: 8

Polar Surface Area: 185.95

Molecular Species: ZWITTERION

HBA: 10

HBD: 6

#RO5 Violations: 1

HBA (Lipinski): 11

HBD (Lipinski): 8

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 2.77

CX Basic pKa: 9.19

CX LogP: -5.82

CX LogD: -5.85

Aromatic Rings: 1

Heavy Atoms: 25

QED Weighted: 0.27

Np Likeness Score: 0.96

References

1. Lamiable-Oulaidi F, Harijan RK, Shaffer KJ, Crump DR, Sun Y, Du Q, Gulab SA, Khan AA, Luxenburger A, Woolhouse AD, Sidoli S, Tyler PC, Schramm VL..  (2022)  Synthesis and Characterization of Transition-State Analogue Inhibitors against Human DNA Methyltransferase 1.,  65  (7.0): [PMID:35324190] [10.1021/acs.jmedchem.1c01869]

Source

Source(1):

• Scientific Literature